CK-MB Test Kit
- UID
- MFG/IVD/2020/000082_ee5de77f691245d1e917a85990e704cf_6271544e872ff56f02167ae0e1c4bc3c
- Device class
- Class B
- Brand name
- BIOGENIX
- License holder
- Biogenix Inc. Pvt. Ltd.
- Approving authority
- Uttar Pradesh
- Product information
- CK-MB is Dry fluorescence Immunoassay for the quantitative determination of Creatine Kinase Isoenzyme-MB (BIOGENIX) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardiac infarction (BIOGENIX) and acute coronary syndrome (BIOGENIX)
CK-MB Test Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000082_ee5de77f691245d1e917a85990e704cf_6271544e872ff56f02167ae0e1c4bc3c. This device is marketed under the brand name BIOGENIX. The license holder is Biogenix Inc. Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Uttar Pradesh.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.